| Particulars |
|
|
|
| Company Name
| Alembic Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
39.31 |
B.V. (₹) |
285.70 |
| Sales(₹ Cr.) |
6,651.38 |
NP (₹ Cr.) |
695.62 |
| NP Var% |
42.00 |
Div% |
600.00 |
| CPS(₹) |
51.20 |
EPS (₹) |
35.40 |
| Traded Value(₹ Lakhs) |
51.70 |
52 Week High |
1,108.00 |
| 52 Week Low |
635.00 |
Price BSE |
755.00 |
| Price NSE |
756.00 |
Market Capital (₹ Cr.) |
14,849.36 |
| P/C Ratio |
14.70 |
P/E Ratio |
21.30 |
| Price Vs.BV |
2.64 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
1,718.74 |
| NP(₹ Cr.) |
263.29 |
NP Var % |
249.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
6,118.85 |
| OPM |
20.32 |
NP |
766.41 |
| NP Var% |
42.27 |
EPS |
35.39 |
| PE |
21.35 |
|
|